FDA Seeks Regulatory Science ‘Bridge’ To Find Pharmacogenomics Biomarkers
This article was originally published in The Pink Sheet Daily
Executive Summary
Incoming Acting Commissioner Stephen Ostroff co-authors paper urging standardization of bioinformatics to speed development of safety and efficacy markers.